Skip to main content
Caplight Logo









At-home-doc

At-home-doc

Private
DohaHealthcare & Life Scienceshttps://at-home-doc.com/en

Last Round

Series A

Jan 3, 2023

Total Funding Raised

$3.4M

Company Overview

At-home-doc operates in Healthcare & Life Sciences and is based in Doha. Its latest recorded funding round was a Series A round in January 2023.

At-home-doc is a healthtech company that provides an on-demand mobile platform for home-based medical consultations, laboratory services, and medication delivery.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, InsurTech

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

At-home-doc Comparables

Compare At-home-doc with similar companies based on industry and business-model similarity.

At-home-doc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sanar
88%
TruDoc Healthcare
81%
Eshfaa
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

At-home-doc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 3, 2023
SeedJul 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

At-home-doc Investors

Notable investors and investment history

At-home-doc investors
InvestorRounds
SeedstarsSeed
500 GlobalSeed
Qatar Development BankSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 121% MoM, reaching 1.9K.

  • Mar 2, 2026

    Monthly visitors increased 830% MoM to 6.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

At-home-doc Filings

Explore SEC and related filing metadata, where available.

At-home-doc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about At-home-doc's valuation, stock price, and market status.

Is At-home-doc a public or private company?

At-home-doc is a private company.

What is the current stock price of At-home-doc?

At-home-doc is a private company, so its shares have no public market price. Caplight tracks At-home-doc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is At-home-doc worth (valuation)?

Valuation information for At-home-doc is not publicly available.

Can I buy At-home-doc stock?

At-home-doc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was At-home-doc's last funding round?

At-home-doc's most recent funding round was Series A on January 3, 2023.

Who are the main investors in At-home-doc?

Key investors in At-home-doc include Seedstars, 500 Global, Qatar Development Bank.

Will At-home-doc IPO soon?

No public IPO plans have been announced for At-home-doc.

How can I track At-home-doc secondary market activity?

Caplight tracks bids, offers, and trades in At-home-doc's shares on secondary markets.

Firmographic Details

HeadquartersDoha
Employee Range11
Year Founded2015
Last FundingJan 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?